Quoin Pharmaceuticals, Ltd. American Depositary Shares (QNRX) Stock Price
QNRXStock
$6.12−17.07%52W
Market Cap$12.29M
P/E—
PEG Ratio—
Div yield—
Beta1.58
QNRX Share Price Chart
Favorite Metrics
Price vs S&P 500 (26W)-41.91%
Price vs S&P 500 (4W)35.99%
VGM Score61.03
QNRX Earnings Surprise History
| Quarter | Report date | EPS estimate | EPS actual | Surprise |
|---|---|---|---|---|
| Q2 2026 | -$1.77 | -$1.90 | -7.15%(-$0.13) | |
| Q1 2026 | -$2.26 | -$1.77 | +21.68%(+$0.49) | |
| Q4 2025 | -$4.02 | -$1.74 | +56.72%(+$2.28) | |
| Q3 2025 | -$1.92 | -$6.70 | -248.78%(-$4.78) | |
| Q2 2025 | -$4.55 | -$6.27 | -37.88%(-$1.72) |
QNRX Analyst Recommendations
May 2026
Jun 2026
Jul 2026
Aug 2026
4.13
4.11
4.10
4.10
Industry Peers — Pharmaceuticals(570)
| Symbol | Value Score | Growth Score | Momentum Score | Price |
|---|---|---|---|---|
QNRXQuoin Pharmaceuticals, Ltd. American Depositary Shares | — | — | B | $6.12 |
| LLYEli Lilly & Co. | D | B | C | $1174.61 |
| JNJJohnson & Johnson | D | C | B | $268.04 |
| ABBVABBVIE INC. | D | C | B | $255.48 |
| MRKMerck & Co., Inc. | D | C | B | $148.35 |
| NVSNovartis AG | C | C | C | $153.81 |
| AZNAstraZeneca PLC | C | B | C | $162.70 |
| NVONovo-Nordisk A/S | B | C | C | $45.61 |
| ABTAbbott Laboratories | C | C | C | $112.47 |
| PFEPfizer Inc. | C | D | B | $27.96 |
| VRTXVertex Pharmaceuticals Inc | D | C | B | $541.69 |
About Quoin Pharmaceuticals, Ltd. American Depositary Shares
Quoin Pharmaceuticals is a clinical-stage specialty pharmaceutical company developing treatments for rare and orphan diseases. The company's pipeline of three products targets multiple indications including Netherton Syndrome, Peeling Skin Syndrome, Palmoplantar Keratoderma, and Epidermolysis Bullosa.